rs149977726
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001953.5(TYMP):c.665A>G(p.Lys222Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001953.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250636Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135826
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461270Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726952
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74340
ClinVar
Submissions by phenotype
Mitochondrial DNA depletion syndrome 1 Pathogenic:3
- -
- -
- -
not provided Pathogenic:2
The K222R variant in the TYMP gene has previously been reported association with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome in an individual who was also heterozygous for frameshift variant in TYMP although the phase of these variants was not determined (Giordano et al., 2008). The K222R variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The K222R variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species and is predicted to be involved in phosphate binding within the activite site of the thymidine phosphorylase enzyme (Nishino et al., 1999; Pugmire et al., 1998). Additionally, in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
This variant is also known as A2744G. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TYMP protein function. ClinVar contains an entry for this variant (Variation ID: 16656). This missense change has been observed in individual(s) with mitochondrial neurogastrointestinal encephalopathy (PMID: 9924029). This variant is present in population databases (rs149977726, gnomAD 0.03%). This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 222 of the TYMP protein (p.Lys222Arg). -
Mitochondrial neurogastrointestinal encephalomyopathy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at